Alberto Lázaro

15PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)EcohydrologyPredictive and prognostic markersMolecular targetsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 16, 2026
Cilastatin Protects Against Chemotherapy-Induced Neuropathy via the FKBP51/DPEP1 Axis: Confocal Insights into Protein Dynamics.

|Feb 20, 2026
Recurrent intermittent hyponatremia: A new experimental model.

Marta Tejedor, Lorena Cussó, María Ángeles González-Nicolás

|Aug 28, 2025
Cilastatin Attenuates Acute Kidney Injury and Reduces Mortality in a Rat Model of Sepsis.

María Ángeles González-Nicolás, Blanca Humanes, Raquel Herrero

|Aug 27, 2025
Cilastatin Modulates DPEP1- and IQGAP1-Associated Neuro-Glio-Vascular Inflammation in Oxaliplatin-Induced Peripheral Neurotoxicity.

Rita Martín-Ramírez, María Ángeles González-Nicolás, Karen Álvarez-Tosco

|Sep 28, 2024
Changes in AmotL2 Expression in Cells of the Human Enteral Nervous System in Oxaliplatin-Induced Enteric Neuropathy.

Rebeca González-Fernández, Rita Martín-Ramírez, María-Del-Carmen Maeso

|May 28, 2024
Tubular biomarkers in proteinuric kidney disease: histology correlation and kidney prognosis of tubular biomarkers.

Javier Carbayo, Úrsula Verdalles, Francisco Díaz-Crespo

Pageof 3

Frequent Collaborators

5 joint publications

María Ángeles González-Nicolás

4 joint publications

Pablo Martín-Vasallo

4 joint publications

Julio Ávila

3 joint publications

Rita Martín-Ramírez